Rafael Selbach Scheffel (Rafael S Scheffel)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Sentinel Lymph Node

Placebo Controlled

Ankylosing Spondylitis

Cognitive Impairment

Top Venues

American journal of cardiovascular drugs : drugs, devices, and other interventions

Reviews in endocrine & metabolic disorders

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme

This page only lists publications with an associated author ORCID identifier.

Publications

Fabián Pitoia, Rafael Selbach Scheffel, Inés Califano, Alicia Gauna, Hernán Tala, Fernanda Vaisman, Alejandro Roman Gonzalez, Ana Oliveira Hoff, Ana Luiza Silva Maia
Management of radioiodine refractory differentiated thyroid cancer: the Latin American perspective. Reviews in endocrine & metabolic disorders (2023)
Wallace Klein Schwengber, Vitor Bock Silveira, Guilherme Moreira Hetzel, Amanda Robaina, Lucieli Ceolin, Marli Teresinha Camelier, Iuri Martin Goemann, Roberta Rigo Dalla Corte, Rafael Selbach Scheffel, Renato Gorga Bandeira de Mello, Ana Luiza Maia, José Miguel S Dora
Type 2 Deiodinase Thr92Ala Polymorphism Is Not Associated with Cognitive Impairment in Older Adults: A Cross-Sectional Study. Metabolites 12 (5) (2022)
Filipe Ferrari, Rafael Selbach Scheffel, Vítor Magnus Martins, Raul Dias Dos Santos Filho, Ricardo Stein
Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus and Cardiovascular Disease: The Past, Present, and Future. American journal of cardiovascular drugs : drugs, devices, and other interventions 22 (4) (2021)
Carla Fernanda Nava, Rafael Selbach Scheffel, André Borsatto Zanella, Flavio Zelmanovitz, Ana Luiza Silva Maia, José Miguel S Dora
Reappraising the Diagnostic Accuracy of Post-Treatment Whole-Body Scans for Differentiated Thyroid Carcinoma. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 52 (12) (2020)